Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.
Liang L, Zhang Y, Li C, Liao Y, Wang G, Xu J, Li Y, Yuan G, Sun Y, Zhang R, Li X, Nian W, Zhao J, Zhang Y, Zhu X, Wen X, Cai S, Li N, Wu L. Liang L, et al. Among authors: liao y. EBioMedicine. 2022 Sep;83:104222. doi: 10.1016/j.ebiom.2022.104222. Epub 2022 Aug 13. EBioMedicine. 2022. PMID: 35973389 Free PMC article.
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma.
Qu W, Fu C, Han W, Luo H, Quan J, Chen L, Liao Y, Hu C, Hu H, Niu Y, Xu D, Chen M, Chen J, Liu Y, Chen G, Luo Z, Shi B, Sun Y, Zhou F, Zhou A. Qu W, et al. Among authors: liao y. Eur J Cancer. 2024 May 10;205:114096. doi: 10.1016/j.ejca.2024.114096. Online ahead of print. Eur J Cancer. 2024. PMID: 38772302
10,491 results
You have reached the last available page of results. Please see the User Guide for more information.